Histopathology-validated lesion detection rates of clinically significant prostate cancer with mpMRI, [(68)Ga]PSMA-11-PET and [(11)C]Acetate-PET

OBJECTIVE: PET/CT and multiparametric MRI (mpMRI) are important diagnostic tools in clinically significant prostate cancer (csPC). The aim of this study was to compare csPC detection rates with [(68)Ga]PSMA-11-PET (PSMA)-PET, [(11)C]Acetate (ACE)-PET, and mpMRI with histopathology as reference, to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandgren, Kristina, Strandberg, Sara N., Jonsson, Joakim H., Grefve, Josefine, Keeratijarut Lindberg, Angsana, Nilsson, Erik, Bergh, Anders, Söderkvist, Karin, Thellenberg Karlsson, Camilla, Friedrich, Bengt, Widmark, Anders, Blomqvist, Lennart, Berg Loegager, Vibeke, Axelsson, Jan, Ögren, Mattias, Ögren, Margareta, Nyholm, Tufve, Riklund, Katrine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566593/
https://www.ncbi.nlm.nih.gov/pubmed/37615497
http://dx.doi.org/10.1097/MNM.0000000000001743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566593/
https://www.ncbi.nlm.nih.gov/pubmed/37615497
http://dx.doi.org/10.1097/MNM.0000000000001743

Ejemplares similares